Home LiteratureArticle Details
PMID: 9041627 Published · ppublish English Journal Article Review

The internal thioester and the covalent binding properties of the complement proteins C3 and C4.

Protein science : a publication of the Protein Society ·Vol. 6 ·No. 2 ·1997-02-00 ·Pages 263-74

Law SK, Dodds AW

Abstract

The covalent binding of complement components C3 and C4 is critical for their activities. This reaction is made possible by the presence of an internal thioester in the native protein. Upon activation, which involves a conformational change initiated by the cleavage of a single peptide bond, the thioester becomes available to react with molecules with nucleophilic groups. This description is probably sufficient to account for the binding of the C4A isotype of human C4 to amino nucleophiles. The binding of the C4B isotype, and most likely C3, to hydroxyl nucleophiles, however, involves a histidine residue, which attacks the thioester to form an intramolecular acyl-imidazole bond. The released thiolate anion then acts as a base to catalyze the binding of hydroxyl nucleophiles, including water, to the acyl function. This mechanism allows the complement proteins to bind to the hydroxyl groups of carbohydrates found on all biological surfaces, including the components of bacterial cell walls. In addition, the fast hydrolysis of the thioester provides a means to contain this very damaging reaction to the immediate proximity of the site of activation.

MeSH Terms
Complement C3/metabolism Complement C4/metabolism Esters/metabolism Humans Protein Binding Sulfhydryl Compounds/metabolism
Chemicals
Complement C3 Complement C4 Esters Sulfhydryl Compounds
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Law S K
Department of Biochemistry, University of Oxford, United Kingdom. alaw@molbiol.ox.ac.uk
Dodds A W
References (66)
66 references, click to expand
  1. Hemolytic activity of lipoprotein-depleted serum and the effect of certain anions on complement.
    J Immunol. 1966 Nov;97(5):680-5 PMID: 5926456
  2. Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement.
    J Exp Med. 1967 Feb 1;125(2):359-80 PMID: 6019133
  3. The effect of residue 1106 on the thioester-mediated covalent binding reaction of human complement protein C4 and the monomeric rat alpha-macroglobulin alpha 1 I3.
    FEBS Lett. 1995 Jul 10;368(1):87-91 PMID: 7542207
  4. Tyrosine is a potential site for covalent attachment of activated complement component C3.
    Mol Immunol. 1995 Jul;32(10):711-6 PMID: 7659097
  5. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway.
    Biochem J. 1989 Feb 1;257(3):831-8 PMID: 2784671
  6. Physico-chemical characteristics of the third and fourth component of complement after dissociation from complement-cell complexes.
    Immunology. 1967 Sep;13(3):293-305 PMID: 6054730
  7. Two HLA-linked loci controlling the fourth component of human complement.
    Proc Natl Acad Sci U S A. 1978 Oct;75(10):5165-9 PMID: 368809
  8. C5 convertase of the alternative complement pathway: covalent linkage between two C3b molecules within the trimolecular complex enzyme.
    J Immunol. 1988 Dec 1;141(11):3895-901 PMID: 3183384
  9. Interaction between the third complement protein and cell surface macromolecules.
    Proc Natl Acad Sci U S A. 1977 Jul;74(7):2701-5 PMID: 268620
  10. Cleavage of structural proteins during the assembly of the head of bacteriophage T4.
    Nature. 1970 Aug 15;227(5259):680-5 PMID: 5432063
  11. The complement component C4 of mammals.
    Biochem J. 1990 Jan 15;265(2):495-502 PMID: 2302180
  12. An equilibrium model of the metastable binding sites of alpha 2-macroglobulin and complement proteins C3 and C4.
    J Biol Chem. 1982 Oct 25;257(20):11864-7 PMID: 6181062
  13. Covalent binding properties of the human complement protein C4 and hydrolysis rate of the internal thioester upon activation.
    Protein Sci. 1993 May;2(5):706-16 PMID: 8495193
  14. MHC genes in autoimmunity.
    Curr Opin Immunol. 1993 Dec;5(6):887-93 PMID: 8297520
  15. Nucleophilic modification of human complement protein C3: correlation of conformational changes with acquisition of C3b-like functional properties.
    Biochemistry. 1981 Jul 21;20(15):4458-67 PMID: 7284336
  16. The molecular basis for the difference in immune hemolysis activity of the Chido and Rodgers isotypes of human complement component C4.
    J Immunol. 1984 Jun;132(6):3019-27 PMID: 6609966
  17. The origin of the very variable haemolytic activities of the common human complement component C4 allotypes including C4-A6.
    EMBO J. 1985 Sep;4(9):2239-44 PMID: 3852741
  18. Evidence for presence of an internal thiolester bond in third component of human complement.
    Proc Natl Acad Sci U S A. 1980 Oct;77(10):5764-8 PMID: 6934510
  19. The esterase-like activity of covalently bound human third complement protein.
    Mol Immunol. 1988 Sep;25(9):821-8 PMID: 3264882
  20. Ovostatin: a novel proteinase inhibitor from chicken egg white. II. Mechanism of inhibition studied with collagenase and thermolysin.
    J Biol Chem. 1983 Jun 25;258(12):7490-8 PMID: 6305943
  21. Kinetic studies of the formation of the properdin system enzymes on zymosan: evidence that nascent C3b controls the rate of assembly.
    J Immunol. 1974 Mar;112(3):1115-23 PMID: 4811964
  22. Substitution of a single amino acid (aspartic acid for histidine) converts the functional activity of human complement C4B to C4A.
    Proc Natl Acad Sci U S A. 1990 Sep;87(17):6868-72 PMID: 2395880
  23. Mechanism of insulin incorporation into alpha 2-macroglobulin: implications for the study of peptide and growth factor binding.
    Biochemistry. 1991 Feb 12;30(6):1551-60 PMID: 1704257
  24. A comparison of the properties of two classes, C4A and C4B, of the human complement component C4.
    EMBO J. 1984 Aug;3(8):1819-23 PMID: 6332733
  25. The enhancement of bacterial phagocytosis by serum. The role of complement components and two cofactors.
    J Exp Med. 1969 Jun 1;129(6):1275-90 PMID: 4181833
  26. Autolytic fragmentation of complement components C3 and C4 under denaturing conditions, a property shared with alpha 2-macroglobulin.
    Biochem J. 1981 Jan 1;193(1):129-41 PMID: 7305917
  27. C3 binds with similar efficiency to Fab and Fc regions of IgG immune aggregates.
    Eur J Immunol. 1994 Mar;24(3):599-604 PMID: 8125130
  28. The purification and properties of some less common allotypes of the fourth component of human complement.
    Immunogenetics. 1986;24(5):279-85 PMID: 2430883
  29. Synthetic lactam and thiolactone models of protein metastable binding sites.
    Ann N Y Acad Sci. 1983;421:167-77 PMID: 6202193
  30. Structural basis of the binding specificity of the thioester-containing proteins, C4, C3 and alpha-2-macroglobulin.
    Complement. 1988;5(2):89-97 PMID: 2454175
  31. Studies on the mechanism of solubilization of immune precipitates by serum.
    J Exp Med. 1976 Mar 1;143(3):615-30 PMID: 1249522
  32. Formation of covalent complexes between the fourth component of human complement and IgG immune aggregates.
    Complement. 1987;4(1):21-32 PMID: 3568629
  33. Covalent binding of C3b to C4b within the classical complement pathway C5 convertase. Determination of amino acid residues involved in ester linkage formation.
    J Biol Chem. 1992 Feb 25;267(6):4171-6 PMID: 1740458
  34. The structural basis of the multiple forms of human complement component C4.
    Cell. 1984 Apr;36(4):907-14 PMID: 6546707
  35. Sequence determination of the thiolester site of the fourth component of human complement.
    Proc Natl Acad Sci U S A. 1981 Dec;78(12):7388-92 PMID: 6950384
  36. The Action of Ammonia on Complement. The Fourth Component.
    Biochem J. 1926;20(5):1028-35 PMID: 16743737
  37. Molecular basis of complement C3 deficiency in guinea pigs.
    J Clin Invest. 1990 Jul;86(1):96-106 PMID: 1973176
  38. Spontaneous thioester bond formation in alpha 2-macroglobulin, C3 and C4.
    FEBS Lett. 1992 Aug 24;308(3):280-2 PMID: 1380468
  39. Reactive site in human alpha 2-macroglobulin: circumstantial evidence for a thiolester.
    Proc Natl Acad Sci U S A. 1981 Apr;78(4):2235-9 PMID: 6166004
  40. Conformational and functional changes in the fourth component of human complement produced by nucleophilic modification and by proteolysis with C1s-.
    Biochemistry. 1982 Mar 16;21(6):1109-17 PMID: 6978735
  41. alpha 2-Macroglobulin, complement, and biologic defense: antigens, growth factors, microbial proteases, and receptor ligation.
    Lab Invest. 1994 Dec;71(6):792-812 PMID: 7528831
  42. Binding of C3b proceeds by a transesterification reaction at the thiolester site.
    Nature. 1982 Jul 1;298(5869):72-5 PMID: 6806664
  43. Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement.
    J Exp Med. 1980 Oct 1;152(4):1102-14 PMID: 6903192
  44. Investigation of mechanism-based inhibitors of complement targeting the activated thioester of human C3.
    Biochem Pharmacol. 1996 Mar 22;51(6):797-804 PMID: 8602875
  45. Heat-induced fragmentation of human alpha 2-macroglobulin.
    J Biol Chem. 1979 Sep 10;254(17):8669-78 PMID: 89116
  46. Specificity of the thioester-containing reactive site of human C3 and its significance to complement activation.
    Biochem J. 1994 Sep 1;302 ( Pt 2):429-36 PMID: 8092994
  47. Binding reaction between the third human complement protein and small molecules.
    Biochemistry. 1981 Dec 22;20(26):7457-63 PMID: 7326238
  48. Non-enzymic activation of the covalent binding reaction of the complement protein C3.
    Biochem J. 1983 May 1;211(2):381-9 PMID: 6870837
  49. Evidence from sequence analysis that hen egg-white ovomacroglobulin (ovostatin) is devoid of an internal beta-Cys-gamma-Glu thiol ester.
    Biochim Biophys Acta. 1993 Mar 5;1162(1-2):230-2 PMID: 7680577
  50. Ovostatin: a novel proteinase inhibitor from chicken egg white. I. Purification, physicochemical properties, and tissue distribution of ovostatin.
    J Biol Chem. 1983 Jun 25;258(12):7481-9 PMID: 6408074
  51. Amino acid sequence around the thiol and reactive acyl groups of human complement component C4.
    Biochem J. 1981 Nov 1;199(2):359-70 PMID: 6978711
  52. Covalent attachment of human complement C3 to IgG. Identification of the amino acid residue involved in ester linkage formation.
    J Biol Chem. 1994 Nov 18;269(46):28997-9002 PMID: 7961863
  53. The opsonic fragment of the third component of human complement (C3).
    J Exp Med. 1975 Jun 1;141(6):1329-47 PMID: 236357
  54. Binding of soluble immune complexes to human lymphoblastoid cells. I. Characterization of receptors for IgG Fc and complement and description of the binding mechanism.
    J Exp Med. 1974 Oct 1;140(4):877-94 PMID: 4139225
  55. Inherited structural polymorphism of the fourth component of human complement.
    Proc Natl Acad Sci U S A. 1980 Jun;77(6):3576-80 PMID: 6932037
  56. The thioester and isotypic sites of complement component C4 in sheep and cattle.
    Immunogenetics. 1993;37(2):120-8 PMID: 8423050
  57. Nucleotide sequence of cDNA encoding human alpha 2-macroglobulin and assignment of the chromosomal locus.
    Proc Natl Acad Sci U S A. 1985 Apr;82(8):2282-6 PMID: 2581245
  58. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man.
    Proc Natl Acad Sci U S A. 1983 Jan;80(1):259-63 PMID: 6401863
  59. Complement polymorphism, the major histocompatibility complex and associated diseases: a speculation.
    Mol Biol Med. 1983 Jul;1(1):161-8 PMID: 6679872
  60. Human complement component C3: cDNA coding sequence and derived primary structure.
    Proc Natl Acad Sci U S A. 1985 Feb;82(3):708-12 PMID: 2579379
  61. Third component of trout complement. cDNA cloning and conservation of functional sites.
    J Immunol. 1993 Dec 1;151(11):6123-34 PMID: 8245455
  62. Complete nucleotide and derived amino acid sequences of the fourth component of mouse complement (C4). Evolutionary aspects.
    J Biol Chem. 1985 Sep 15;260(20):10936-43 PMID: 2993295
  63. The requirement for a hydrazine-sensitive serum factor and heat-labile serum factors in the inactivation of human C'3 by zymosan.
    J Immunol. 1953 Nov;71(5):339-45 PMID: 13118170
  64. Localization of the covalent C3b-binding site on C4b within the complement classical pathway C5 convertase, C4b2a3b.
    J Biol Chem. 1990 Aug 25;265(24):14444-9 PMID: 2387864
  65. Third component of human complement: structural requirements for its function.
    Biochemistry. 1980 Sep 16;19(19):4479-85 PMID: 7407086
  66. Structural requirements for thioester bond formation in human complement component C3. Reassessment of the role of thioester bond integrity on the conformation of C3.
    J Biol Chem. 1992 May 15;267(14):10062-9 PMID: 1577777
Article Info
Journal
Protein science : a publication of the Protein Society
Abbr.
Protein Sci
ISSN
0961-8368
Published
1997-02-00
Pages
263-74
Language
English
Region
United States
NLM ID
9211750
PMCID
PMC2143658
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com